Pre-Erythrocytic Vaccines against Malaria
Malaria, caused by the protozoan Plasmodium, is a devastating disease with over 200 million new cases reported globally every year. Although immunization is arguably the best strategy to eliminate malaria, despite decades of research in this area we do not have an effective, clinically approved antimalarial vaccine. The current impetus in the field is to develop vaccines directed at the pre-erythrocytic developmental stages of Plasmodium, utilizing novel vaccination platforms. We here review the most promising pre-erythrocytic stage antimalarial vaccine candidates.
2002 ◽
Vol 357
(1417)
◽
pp. 5-11
◽
2004 ◽
Vol 72
(11)
◽
pp. 6245-6254
◽
2007 ◽
Vol 102
(3)
◽
pp. 335-340
◽
Keyword(s):
1974 ◽
Vol 32
◽
pp. 320-321
Keyword(s):
1978 ◽
Vol 36
(2)
◽
pp. 378-379
1977 ◽
Vol 35
◽
pp. 346-347
2019 ◽
Vol 4
(4)
◽
pp. 633-640
◽